Levofloxacin prophylaxis in patients with myeloma

Lancet Oncol. 2020 Feb;21(2):e68. doi: 10.1016/S1470-2045(20)30008-5.

Authors

Werner C Albrich¹, Katia Boggian²

Affiliations

¹ Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St Gallen, St Gallen CH-9007, Switzerland. Electronic address: werner.albrich@kssg.ch.
² Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St Gallen, St Gallen CH-9007, Switzerland.

PMID: 32007199
DOI: 10.1016/S1470-2045(20)30008-5

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibiotic Prophylaxis
Double-Blind Method
Febrile Neutropenia*
Humans
Levofloxacin
Multiple Myeloma*

Substances

Levofloxacin